These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 2178127)
1. Immunopathogenesis of equine infectious anemia lentivirus disease. McGuire TC; O'Rourke KI; Perryman LE Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127 [TBL] [Abstract][Full Text] [Related]
2. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus. Raabe ML; Issel CJ; Montelaro RC Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665 [TBL] [Abstract][Full Text] [Related]
3. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572 [TBL] [Abstract][Full Text] [Related]
4. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies. Tschetter JR; Byrne KM; Perryman LE; McGuire TC Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283 [TBL] [Abstract][Full Text] [Related]
5. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100 [TBL] [Abstract][Full Text] [Related]
6. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667 [TBL] [Abstract][Full Text] [Related]
7. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252 [TBL] [Abstract][Full Text] [Related]
9. Immunology of a persistent retrovirus infection--equine infectious anemia. McGuire TC; Crawford TB Adv Vet Sci Comp Med; 1979; 23():137-59. PubMed ID: 95154 [No Abstract] [Full Text] [Related]
13. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Hammond SA; Raabe ML; Issel CJ; Montelaro RC Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520 [TBL] [Abstract][Full Text] [Related]
14. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine. Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668 [TBL] [Abstract][Full Text] [Related]
15. Leukoencephalitis associated with selective viral replication in the brain of a pony with experimental chronic equine infectious anemia virus infection. Oaks JL; Long MT; Baszler TV Vet Pathol; 2004 Sep; 41(5):527-32. PubMed ID: 15347829 [TBL] [Abstract][Full Text] [Related]
16. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo. Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of viral persistence in equine infectious anemia. Coggins L Cornell Vet; 1975 Apr; 65(2):143-51. PubMed ID: 165036 [No Abstract] [Full Text] [Related]
18. Hyperglobulinemia and lymphocyte subset changes in naturally infected, inapparent carriers of equine infectious anemia virus. Russell KE; Walker KM; Miller RT; Sellon DC Am J Vet Res; 1998 Aug; 59(8):1009-15. PubMed ID: 9706205 [TBL] [Abstract][Full Text] [Related]
19. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426 [TBL] [Abstract][Full Text] [Related]
20. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus. Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]